PreventionPREV-URGNCT07714460
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures
A study testing personalized preventive health information and non-personalized preventive health information in people with Prevention, run by Centre Hospitalier le Mans at 2 sites in France.
Trial summary
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Prevention
- What is being tested?
- personalized preventive health information and non-personalized preventive health information
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 658 participants
- Where
- 2 sitesFrance
- Study dates
- 27 Jul 2026to 27 Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult patients (≥ 18 years of age)
- Patients seen in the emergency departments of Le Mans University Hospital and the PSSL
- Patients who have given their free and informed oral consent
Who cannot join
- Patients who have previously participated in the study
- Patients with limited understanding of the French language
- Patients unable to give informed consent
- Individuals not enrolled in or not eligible for a social security program
- Individuals deprived of their liberty by judicial or administrative order
- Individuals receiving involuntary psychiatric care
- Individuals subject to a legal protective measure
- Pregnant or breastfeeding patients.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
France2 sites
Pôle Santé Sarthe et Loir
La Flèche, Sarthe, 72205
Cyrielle HOUALARD, MD, +332 44 71 30 00, choualard@ch-lemans.fr
Centre Hospitalier du Mans
Le Mans, Sarthe, 72000
Cyrielle HOUALARD, MD, +332 43 43 43 43, choualard@ch-lemans.fr
About this study
Official title: Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures: A Multicenter, Randomized Controlled Exploratory Trial
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Read more
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
- Conditions
- Prevention
- Being tested
- personalized preventive health information, non-personalized preventive health information
- Keywords
- personalized prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
personalized preventive health informationProcedure or surgery
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
non-personalized preventive health informationProcedure or surgery
The intervention involves providing non-personalized preventive health information. The patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her.
| Study group | Role | What they receive |
|---|---|---|
| A - Intervention | Experimental | The first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them. Receives: Procedure: personalized preventive health information |
| B - Control | Experimental | The second "control" group, designated B, receives non-personalized information. Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her. Receives: Procedure: non-personalized preventive health information |
What is being measured
The primary outcome is the main question the study is designed to answer.
proportion of patients who adhered to at least 25% of the preventive measures
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention.
Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term
Measured: 6-8 weeks after the intervention.
Secondary outcomes (3)
The proportion of patients who adhered to each of the preventive measures studied.
Measured: 6-8 weeks after the intervention.
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Measured: 6-8 weeks after the intervention.
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Measured: 6-8 weeks after the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2026
- Study start27 Jul 2026 (estimated)
- Primary completion27 Nov 2026 (estimated)
- Study completion27 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 658 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier le Mans
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07714460
- Sponsor's protocol ID
- CHM-2025/S02/17
- Acronym
- PREV-URG
- Status last verified
- Jul 2026
- First submitted
- 15 Jul 2026
- Last updated
- 22 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures: A Multicenter, Randomized Controlled Exploratory Trial
- ClinicalTrials.gov ID
- NCT07714460
- Acronym / sponsor ID
- PREV-URG / CHM-2025/S02/17
- Conditions
- Prevention
- Keywords
- personalized prevention
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 658 participants (estimated)
- Lead sponsor
- Centre Hospitalier le MansUniversity, hospital or other
- Study start
- 27 Jul 2026 (estimated)
- Primary completion
- 27 Nov 2026 (estimated)
- Study completion
- 27 Jan 2027 (estimated)
- First posted
- 20 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| A - Intervention | Experimental | Procedure: personalized preventive health informationThe first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them. |
| B - Control | Experimental | Procedure: non-personalized preventive health informationThe second "control" group, designated B, receives non-personalized information. Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adult patients (≥ 18 years of age)
- Patients seen in the emergency departments of Le Mans University Hospital and the PSSL
- Patients who have given their free and informed oral consent
Key exclusion criteria (8 listed)
- Patients who have previously participated in the study
- Patients with limited understanding of the French language
- Patients unable to give informed consent
- Individuals not enrolled in or not eligible for a social security program
- Individuals deprived of their liberty by judicial or administrative order
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| personalized preventive health informationThe intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use. | Procedure or surgery | A - Intervention |
| non-personalized preventive health informationThe intervention involves providing non-personalized preventive health information. The patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her. | Procedure or surgery | B - Control |
Primary outcome
proportion of patients who adhered to at least 25% of the preventive measures
Time frame: 6-8 weeks after the intervention.
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term
3 secondary outcomes
The proportion of patients who adhered to each of the preventive measures studied.
Time frame: 6-8 weeks after the intervention.
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Time frame: 6-8 weeks after the intervention.
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Time frame: 6-8 weeks after the intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jul 2026.
Related trials for Prevention
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Not yet recruiting
Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department
Opioid Overdose Prevention, HIV Prevention and Care
Recruiting
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
Suicide, Attempted, Suicide Ideation
Recruiting
Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities
Disabilities Physical, Falls
Active, not recruiting
This Research Proposal Focuses on Evaluating the Effectiveness of a Nursing Care Protocol in Preventing Deep Vein Thrombosis (DVT) in Patients Undergoing On-pump Cardiac Surgery. The Study Will Include an Intervention Group That Receives the Nursing Protocol and a Control Group That Receives Routine
On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications, DVT - Deep Vein Thrombosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing personalized preventive health information and non-personalized preventive health information in people with Prevention, run by Centre Hospitalier le Mans at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Christelle JADEAU (+332 44 71 07 81, cjadeau@ch-lemans.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
proportion of patients who adhered to at least 25% of the preventive measures (time frame: 6-8 weeks after the intervention.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026; AzTrials last refreshed its copy on 6 Nov 2026.